- BioVector NTCC典型培养物保藏中心
- 联系人:Dr.Xu, Biovector NTCC Inc.
电话:400-800-2947 工作QQ:1843439339 (微信同号)
邮件:Biovector@163.com
手机:18901268599
地址:北京
- 已注册
ANBL6 BR
Cell line name ANBL-6 BRAccession CVCL_QZ43Resource Identification Initiative To cite this cell line use: ANBL-6 BR (RRID:CVCL_QZ43)Comments Characteristics: Produces Ig lambda.Characteristics: IL6 dependent.Selected for resistance to: ChEBI; CHEBI:52717; Bortezomib (Velcade).Derived from sampling site: Peripheral blood.Sequence variations Mutation; HGNC; 12033; TRAF3; Simple; p.Tyr425Thrfs*36 (c.1272delC); Zygosity=Homozygous (from parent cell line).Disease Plasma cell myeloma (NCIt: C3242)Multiple myeloma (ORDO: Orphanet_29073)Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)Hierarchy Parent: CVCL_5425 (ANBL-6)Sex of cell FemaleAge at sampling 67YCategory Cancer cell linePublications PubMed=19344406; DOI=10.1111/j.1365-2141.2009.07647.xVoorhees P.M., Chen Q., Small G.W., Kuhn D.J., Hunsucker S.A., Nemeth J.A., Orlowski R.Z.Targeted inhibition of interleukin-6 with CNTO 328 sensitizes pre-clinical models of multiple myeloma to dexamethasone-mediated cell death.Br. J. Haematol. 145:481-490(2009)
Supplier来源:BioVector NTCC Inc.
TEL电话:+86-010-53513060
Website网址: http://www.biovector.net
Cell line name ANBL-6 BRAccession CVCL_QZ43Resource Identification Initiative To cite this cell line use: ANBL-6 BR (RRID:CVCL_QZ43)Comments Characteristics: Produces Ig lambda.Characteristics: IL6 dependent.Selected for resistance to: ChEBI; CHEBI:52717; Bortezomib (Velcade).Derived from sampling site: Peripheral blood.Sequence variations Mutation; HGNC; 12033; TRAF3; Simple; p.Tyr425Thrfs*36 (c.1272delC); Zygosity=Homozygous (from parent cell line).Disease Plasma cell myeloma (NCIt: C3242)Multiple myeloma (ORDO: Orphanet_29073)Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)Hierarchy Parent: CVCL_5425 (ANBL-6)Sex of cell FemaleAge at sampling 67YCategory Cancer cell linePublications PubMed=19344406; DOI=10.1111/j.1365-2141.2009.07647.xVoorhees P.M., Chen Q., Small G.W., Kuhn D.J., Hunsucker S.A., Nemeth J.A., Orlowski R.Z.Targeted inhibition of interleukin-6 with CNTO 328 sensitizes pre-clinical models of multiple myeloma to dexamethasone-mediated cell death.Br. J. Haematol. 145:481-490(2009)
Supplier来源:BioVector NTCC Inc.
TEL电话:+86-010-53513060
Website网址: http://www.biovector.net
您正在向 biovector.net 发送关于产品 ANBL6 BR BioVector NTCC质粒载体菌种细胞基因保藏中心 的询问
- 公告/新闻